Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Prothena Corp Public (PRTA) over the last 13 years, with Q1 2025 value amounting to $44.9 million.

  • Prothena Corp Public's Long-Term Deferred Tax rose 2245.67% to $44.9 million in Q1 2025 from the same period last year, while for Mar 2025 it was $44.9 million, marking a year-over-year increase of 2245.67%. This contributed to the annual value of $43.2 million for FY2024, which is 2757.5% up from last year.
  • Prothena Corp Public's Long-Term Deferred Tax amounted to $44.9 million in Q1 2025, which was up 2245.67% from $43.2 million recorded in Q4 2024.
  • In the past 5 years, Prothena Corp Public's Long-Term Deferred Tax ranged from a high of $44.9 million in Q1 2025 and a low of $6.4 million during Q2 2021
  • For the 5-year period, Prothena Corp Public's Long-Term Deferred Tax averaged around $23.4 million, with its median value being $21.4 million (2023).
  • Per our database at Business Quant, Prothena Corp Public's Long-Term Deferred Tax plummeted by 4356.99% in 2021 and then skyrocketed by 15744.59% in 2022.
  • Prothena Corp Public's Long-Term Deferred Tax (Quarter) stood at $7.1 million in 2021, then skyrocketed by 157.45% to $18.2 million in 2022, then soared by 86.18% to $33.9 million in 2023, then grew by 27.58% to $43.2 million in 2024, then rose by 3.87% to $44.9 million in 2025.
  • Its last three reported values are $44.9 million in Q1 2025, $43.2 million for Q4 2024, and $41.0 million during Q3 2024.